• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

argenx

Paragliding near Tu Le valley with landscape with green and yellow rice fields and blue cloudy sky  North- Vietnam
Biotech

Former Roche oncology head turns to Tubulis—Chutes & Ladders

Former Roche oncology head turns to Tubulis. Argenx CEO passes baton to operating chief. Longtime Charles River leader eyes retirement.
Darren Incorvaia , Zoey Becker Jan 9, 2026 8:30am
Sunrise over foggy forest in Tuscany Italy

Versant's Dayra dawns with $50M Biogen pact

Nov 24, 2025 10:28am
business targets illustration

Argenx's $1.5B pact to turn macrocyclic peptides to new targets

Jul 1, 2025 8:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Leo's eczema prospect hits primary endpoint in phase 2b

May 9, 2025 7:30am
target reach ladder climb meet win beat competition

J&J's phase 2 Sjögren's data support FcRn strategy

Jun 17, 2024 8:47am
graphic image of a cube with an arrow nailing the bullseye

Roivant FcRn inhibitor avoids cholesterol problem, shares spike

Sep 26, 2023 10:56am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings